Eubel Brady & Suttman Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $225K | Hold |
|
|||||
|
2024
Q4 | $209K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $206K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $284K | Sell |
|
|||||
|
2021
Q1 | $568K | Buy |
|
|||||
|
2020
Q4 | $255K | Hold |
|
|||||
|
2020
Q3 | $247K | Buy |
|
|||||
|
2020
Q2 | $227K | Hold |
|
|||||
|
2020
Q1 | $216K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $207K | Hold |
|
|||||
|
2018
Q3 | $247K | Hold |
|
|||||
|
2018
Q2 | $220K | Sell |
|
|||||
|
2018
Q1 | $296K | Sell |
|
|||||
|
2017
Q4 | $357K | Hold |
|
|||||
|
2017
Q3 | $371K | Hold |
|
|||||
|
2017
Q2 | $324K | Hold |
|
|||||
|
2017
Q1 | $317K | Sell |
|
|||||
|
2016
Q4 | $383K | Buy |
|
|||||
|
2016
Q3 | $353K | Buy |
|
|||||
|
2016
Q2 | $423K | Sell |
|
|||||
|
2016
Q1 | $411K | Buy |
|
|||||
|
2015
Q4 | $405K | Hold |
|
|||||
|
2015
Q3 | $349K | Sell |
|
|||||
|
2015
Q2 | $460K | Sell |
|
|||||
|
2015
Q1 | $447K | Buy |
|
|||||
|
2014
Q4 | $388K | Sell |
|
|||||
|
2014
Q3 | $356K | Hold |
|
|||||
|
2014
Q2 | $338K | Hold |
|
|||||
|
2014
Q1 | $362K | Buy |
|
|||||
|
2013
Q4 | $359K | Buy |
|
|||||
|
2013
Q3 | $303K | Hold |
|
|||||
|
2013
Q2 | $292K | Buy |
|